Back to Search
Start Over
Tarsus posts positive results on eyedrop treatment for eyelid mange, expects to file for FDA approval next year.
- Source :
- FierceBiotech; 6/21/2021, pN.PAG-N.PAG, 1p
- Publication Year :
- 2021
-
Abstract
- Tarsus Pharmaceuticals met all primary and secondary endpoints in a pivotal phase 2b/3 trial of its eyedrop treatment for eyelid mange, and expects to file for regulatory approval next year following results of another pivotal study already underway. [ABSTRACT FROM AUTHOR]
- Subjects :
- MITE infestations
EYELIDS
DRY eye syndromes
REGULATORY approval
Subjects
Details
- Language :
- English
- Database :
- Complementary Index
- Journal :
- FierceBiotech
- Publication Type :
- Periodical
- Accession number :
- 151047042